Tag: NeonMind - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets

NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets

Post published:September 13, 2021
Post category:Press Release

Read more about the article NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

Post published:March 11, 2021
Post category:Press Release

Read more about the article NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity

NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity

Post published:March 9, 2021
Post category:Press Release

Read more about the article NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data

Post published:March 2, 2021
Post category:Press Release

Read more about the article NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial

NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial

Post published:February 24, 2021
Post category:Press Release

Read more about the article NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress

NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress

Post published:February 10, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

Post published:January 27, 2021
Post category:Press Release

Read more about the article NeonMind Lists on the Frankfurt Stock Exchange

NeonMind Lists on the Frankfurt Stock Exchange

Post published:January 19, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

Post published:January 14, 2021
Post category:Press Release

Read more about the article NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

Post published:January 12, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.